This case report demonstrates the feasibility of radiofrequency ablation for Wolff-Parkinson-White syndrome in a patient with a prior tricuspid valve replacement for Ebstein's anomaly.
Answers are grounded in this paper and cite their sources.
Supports feasibility of accessory pathway ablation after tricuspid replacement; leaves open safety and efficacy in larger Ebstein's cohorts.
Ebstein's anomaly of the tricuspid valve has a known association with the Wolff-Parkinson-White syndrome. Radiofrequency ablation has become the treatment of choice for the latter, but there have been no reports of the feasibility of this procedure after tricuspid valve replacement. We present a patient who first exhibited evidence of intermittent preexcitation and associated symptomatic arrhythmia 9 years after tricuspid valve replacement for Ebstein's anomaly, and describe the challenges posed by this case.
No takes yet. Share an insight, caveat, or question.
Kocheril et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: